DalsnaFinance › IPOs › Arcus Biosciences Inc › IPO
Arcus Biosciences, Inc. completed its initial public offering on NYSE on March 15, 2018, pricing at $15.00 a share.
| Ticker | RCUS |
|---|---|
| Exchange | NYSE |
| Status | Completed |
| Listing date | March 15, 2018 |
| Offering price | $15.00 |
| Shares offered | 8,000,000 |
| Total raised | $120M |
Arcus Biosciences, Inc. sold 8,000,000 shares at $15.00 each on NYSE. Multiplied out, that is $120 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $120 million total recorded for the deal.
Arcus Biosciences, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Arcus Biosciences, Inc.. This page is general information, not investment advice.